TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.

While February 2nd twenty years ago is listed on Wikipedia as the founding date -- the day when, according to Mike Milinkovich, the first official press release was issued -- the Foundation already ...

FDA grants Breakthrough Device Designation to BioAgilytix’s anti-AAV antibody assay supporting Lexeo’s gene therapy for ...

First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer The SIR clinical community ...

New DVT MCP Server Product Is Available in Latest Release This release is a major milestone for both our team and our ...

Strategies to avoid paying the hefty new visa fee for highly skilled foreigners include recruiting workers who have already ...

Astronauts have been practicing walking on the Moon as their next-generation spacesuit passes milestone testing. NASA astronauts and spacesuit engineers recently simulated lunar surface operations and ...

About two dozen people spoke in favor of continuing the project. The crowd was so large it filled two overflow rooms where ...

CVRx (NASDAQ:CVRX) reported fourth-quarter revenue of $16.0 million and full-year revenue of $56.7 million, representing growth of 4% and 10%, respectively, as the company continued investing in its c ...

The decision reignited a heated debate about government transparency and whether the private vote bypassed public scrutiny.

Sentante announced today that the FDA accepted its stroke treatment system into its Total Product Life Cycle Advisory Program (TAP).

This desktop app for hosting and running LLMs locally is rough in a few spots, but still useful right out of the box.